Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort

• Main Authors: Jan Sperl (Author), Miluse Kreidlova (Author), Dusan Merta (Author), Klara Chmelova (Author), Renata Senkerikova (Author), Sona Frankova (Author)
• Formato: Libro
• Publicado: Karger Publishers, 2018-04-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Background/Aims: Chronic hepatitis C (HCV) virus infection reactivates under immunosuppressive drugs and therefore has a negative impact on long-term survival of kidney transplant recipients. Treatment-induced clearance of hepatitis C virus (HCV) in kidney transplant candidates prevents virus reacti...